Hyundai Pharmaceutical Co., LTD.

Quick facts

Phase 3 pipeline

• Acebrophylline · Other
• BPDO-1603 · Cardiovascular
  BPDO-1603 is a small molecule that targets the renin-angiotensin system to lower blood pressure.

Phase 1 pipeline

• HDDO-1756
• HT-002-01
• Surfolase CR

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Hyundai Pharmaceutical Co., LTD. portfolio CI brief
• Hyundai Pharmaceutical Co., LTD. pipeline updates RSS